Skip to main content

Table 3 Overview of the included studies

From: Effects of caffeine intake on pupillary parameters in humans: a systematic review and meta-analysis

Study

Study design

Blinding method

Within- or between-subjects design

Sample size

Abstinence duration (in hours)

Method of administration

Caffeine dosing

Type of control

Results

Redondo et al. [38]

Crossover study

Double-blind

Within-subjects

22

12

Oral (capsule)

4 mg/kg

Baseline measurement and Placebo

Caffeine significantly increased pupil size compared to placebo

Lanini et al. [39]

Randomised, placebo-controlled, independent-group design study

Double-blind

Between-subjects

60

12

Oral (capsule)

Habitual breakfast dose of caffeine (Ranged between 25 and 300 mg)

Baseline measurement and Placebo

Baseline difference in pupil size between groups; no interaction with time

Abokyi et al. [40]

Double-blind, placebo-controlled, randomised crossover experimental design

Double-blind

Within-subjects

50

168

Oral (drink)

250 mg

Baseline measurement and Placebo

Pupil diameter increased from 3.4 (± 0.4 mm) at baseline to 4.5 (± 0.72 mm) at 90 min

Krueger et al. [41]

Placebo-controlled, within-subject design

Simple-blind

Within-subjects

5

24

Oral (drink)

350 mg caffeine/75 kg bodyweight

Baseline measurement and Placebo

No influence of caffeine on pupil dilation caused by pain

Wilhelm et al. [44]

Open study design

No blinding

Within-subjects

20

9

Oral (drink)

Caffeine content of 86.85 mg per cup (about 1–1.5 mg/kg)

Baseline measurement

Caffeine caused a reduction of pupillary unrest index (PUI)

Bardak et al. [42]

Non-randomised design

No blinding

Within-subjects

30

12

Oral (drink)

57 mg

Baseline measurement

tendency of increased pupil size in the caffeine group

Nicholson et al. [43]

Randomised controlled trial (RCT)

Double-blind

Within-subjects

6

32

Oral (ingestion)

300 mg

Baseline measurement and placebo

No significant changes in pupil size